Black Diamond Therapeutics, Inc.
BDTX
$2.02
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 0.00 | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 0.00 | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | 0.00 | -- | -- |
| SG&A Expenses | 4.66M | 4.26M | 3.97M | 3.54M | 4.10M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.06M | 11.26M | 10.26M | 10.98M | 13.42M |
| Operating Income | -12.06M | -11.26M | -10.26M | -10.98M | -13.42M |
| Income Before Tax | -9.91M | -9.04M | -15.12M | -8.50M | -10.56M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.91M | -9.04M | -15.12M | -8.50M | -10.56M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.91M | -9.04M | -15.12M | -8.50M | -10.56M |
| EBIT | -12.06M | -11.26M | -10.26M | -10.98M | -13.42M |
| EBITDA | -12.03M | -11.23M | -10.20M | -10.89M | -13.33M |
| EPS Basic | -0.17 | -0.16 | -0.26 | -0.15 | -0.19 |
| Normalized Basic EPS | -0.11 | -0.10 | -0.09 | -0.09 | -0.12 |
| EPS Diluted | -0.17 | -0.16 | -0.26 | -0.15 | -0.19 |
| Normalized Diluted EPS | -0.11 | -0.10 | -0.09 | -0.09 | -0.12 |
| Average Basic Shares Outstanding | 57.37M | 57.23M | 57.09M | 56.93M | 56.80M |
| Average Diluted Shares Outstanding | 57.37M | 57.23M | 57.09M | 56.93M | 56.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |